Home   || Site Map ||    Contact Us





  Javed Naim Agrewala


Edit Your Details  
Click Here !!



Name Dr JN Agrewala
(Dr Javed Naim Agrewala)
FNA ID P10-1503
Address Adjunct Professor, Centre for Biomedical Engineering, Indian Institute of Technology Ropar, Nangal Road
City Rupnagar
Pin Code 140001
Country India
Gender Male
Specialization Immunology, Tuberculosis
Service in the Council
Qualification PhD
Membership FNASc, FNA
  Award
  Year of Election 2010  
E-mail jagrewala@iitrpr.ac.in
Personal Website http://imtech.res.in
Summary

Dr. Javed N Agrewala did his BSc, MSc and PhD from Agra University, Agra. In 1989 he joined a faculty position as a scientist at the CSIR-Institute of Microbial Technology, Chandigarh. Dr. Agrewala was a visiting Scientist at the Royal Postgraduate Medical School, Hammersmith Hospital, London, UK [1994-1996] and Trudeau Institute, Saranac Lake, USA [2001-2002]. Currently, Dr. Agrewala is working as a Chief Scientist at the CSIR-Institute of Microbial Technology, Chandigarh.
Academic and Research Achievements: Dr. Agrewala’s group has demonstrated novel and simple vaccination strategies against M. tuberculosis [Eur J Immunol. 1994, J Infect Dis. 2004, Eur J Immunol. 1999, J Proteome Res. 2008, J Infect Dis 2010, PLoSOne 2011, Crit Rev Microbiol. 2011, J Infect Dis 2011, Trends Mol Med 2012, US Patent 6783765)]. His group has also demonstrated that costimulatory molecules can be exploited for regulating the immune response [J Immunol. 1994, 1998, Eur J Immunol. 1994, Clin Exp Immunol. 1998, J Biol Chem. 2002, Clin Exp Immunol. 2007, PLoSOne 2011, J Immunol. 2012, PLoS Pathogens 2012, PLoS One 2013]. His group has also discovered the role of ‘Caerulomycin A’ in suppressing the activity of T cells [US Patent No. 8,114,895]. Dr. Agrewala has also demonstrated that CD4+ T cell memory and effectors have distinct migratory priorities [Adv Exp Med Biol. 2002, Immunol Rev. 2006, J Biol Chem. 2007].
Dr. Agrewala identified the immunosuppressive role of Caerulomycin A. The technology was transferred for USD 3 million to USA based Nostrum Pharmaceutical Company. Dr. RM Vohra and Dr. RS Jolly worked on the Microbiology and Chemistry aspect of the project, respectively.
Other Contributions: Dr. Agrewala has been on editorial board/reviewer for many international journals like PLoS One, BMC Immunology, Recent Patents on Anti-Infective Drug Discovery, Amino Acids, Eur J Immunol, J Neuroimmunol,  Infection Immunity, Clin Exp Immunol., Inflammation Res. J Infect Dis, J Bac, J Proteome Res, Immunology, Vaccine, Cancer Lett, Microbiol Immunol, J Med Microbiol, Brain Behaviour Immunity, Int Immunopharmacol, Hematologia, Exp Parasitol, Polish J Food Nutr Sci, Adv Applied Res, Current Science, J Bioscience, etc. He is a member of several prestigious committees like Shanti Swarup Bhatnagar Advisory Committee-Medical Sciences, Board of Studies, Hamdard University, New Delhi, Selection Committee of Scientists: Indian Institute of Petroleum, Dehradun, Board Nominee: Academy of Scientific and Innovative Research (AcSIR), Expert Member (Biomedicine): Indo-Hungarian bilateral program, Institute’s Animal Ethics Committee, IMTECH, CSIR-Nehru Science Postdoctoral Research Fellowship Scheme, INSPIRE-DST program. He is also a Biosafety Officer, In-charge BSL-3 Laboratory and Animal Facility, IMTECH, Chandigarh.
 
Awards and Honours: Shanti Swarup Bhatnagar Award, Fellow: Indian National Science Academy, Fellow: National Academy of Sciences India, National Bioscience Award for Career Development, New Idea Research Talent Award, Fellowship: Medical Research Council (MRC), U.K.

       History | Significant Landmark | Objectives | Committees | Local Chapters | Rules | Regulations | Current Fellows National | Current Fellows Foreign | Indian Fellows Elected | Foreign Fellows Elected | Pravasi Fellows| Nomination Form | Council |
©Website design and developed by: INDIAN NATIONAL SCIENCE ACADEMY. Informatics Centre